Works matching DE "CHARLES River Laboratories International Inc."
Results: 13
Investors fight Charles River/WuXi merger.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 7, p. 636, doi. 10.1038/nbt0710-636b
- By:
- Publication type:
- Article
Charles River builds drug validation services.
- Published in:
- Nature Biotechnology, 2001, v. 19, n. 3, p. 193, doi. 10.1038/85599
- By:
- Publication type:
- Article
The C57BL/6NCrl-lb Mouse: A New Model for Metabolic Syndrome.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A832, doi. 10.1096/fasebj.21.6.a832-d
- By:
- Publication type:
- Article
Proteins 'R' Us.
- Published in:
- Bio-IT World, 2003, v. 2, n. 6, p. 11
- By:
- Publication type:
- Article
Charles River acquisition of WuXi off.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 831, p. 16
- Publication type:
- Article
Charles River to buy Wuxi for $1.6b.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 828, p. 6
- Publication type:
- Article
General.
- Published in:
- Applied Clinical Trials, 2011, p. 20
- Publication type:
- Article
Mergers/Acquisitions.
- Published in:
- Applied Clinical Trials, 2006, v. 15, n. 7, p. 50
- Publication type:
- Article
Veterinary clinical pathology trainees benefit from toxicologic externship opportunities in the biopharmaceutical industry.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Short term Candida albicans colonization reduces Pseudomonas aeruginosa-related lung injury and bacterial burden in a murine model.
- Published in:
- Critical Care, 2011, v. 15, n. 3, p. 10276, doi. 10.1186/cc10276
- Publication type:
- Article
State-of-the-Art Proteomics Facility Offers Fee-for-Service Research.
- Published in:
- PharmaGenomics, 2003, v. 3, n. 5, p. 16
- Publication type:
- Article
ALZHEIMER'S DISEASE DRUG FAILURES PLAGUE R&D IN NEUROLOGY.
- Published in:
- Applied Clinical Trials, 2019, v. 28, n. 3, p. 15
- Publication type:
- Article
Deals ahead.
- Published in:
- Chemistry & Industry, 2003, n. 15, p. 16
- By:
- Publication type:
- Article